clinicalintelpulse.theaslangroupllc.com

Route probed: GET https://clinicalintelpulse.theaslangroupllc.com/api/clinical/trial-check
Category: eat:gov/regulatory/product (tags: health, people, gov-data, research, content, memory) · Status: listing listed, probe active · Listing: 0.02 USD, 4 payers / 6 calls (30d, Bazaar) · Listed in: agentic-market, cdp-bazaar
Last probe: 2026-10-23T14:04:29Z (4 h ago) · Recent valid 402: 2/2 · p50 1360 ms
probe-only: no paid test-buys yet. No index until 3 paid buys on 3 different days.

Badge:

Paid test-buys

None yet.

402 challenge checks (since 2026-10-23T14:04:29Z)

1 valid 402s checked: terms consistent 0, Base USDC offered 1, price matches listing 1 (differs 0), payTo changed vs previous probe 0.

Unpaid probes (newest first, up to 200; raw receipts are kept 7 days, then in the archive)

Other listed routes

• https://clinicalintelpulse.theaslangroupllc.com/api/clinical/trial-check ClinicalTrials.gov lookup, deterministic. Answers "what is the status of NCT02142738", "recruiting phase-3 melanoma trials", "Pfizer trial pipeline". Single tri (cdp-bazaar)
• https://clinicalintelpulse.theaslangroupllc.com/api/clinical/drug-check What is this medication? Plain-language explainer for any prescription or OTC drug from its FDA-approved label — what it treats, how to take it, boxed warnings, (cdp-bazaar)
• https://clinicalintelpulse.theaslangroupllc.com/api/clinical/trial-brief Clinical trial deep dive by NCT ID — full trial design, primary/secondary endpoints, enrollment status and countries, sponsor, recruitment criteria, outcomes an (cdp-bazaar)
• https://clinicalintelpulse.theaslangroupllc.com/api/clinical/deal-signal Biotech M&A + licensing deal signal for clinical-stage drugs — Phase 2/3 assets most likely to be acquired or licensed, with acquisition targets, deal comps, tr (cdp-bazaar)
• https://clinicalintelpulse.theaslangroupllc.com/api/clinical/recall-check Is my medication recalled? Checks the FDA enforcement databases (drug AND food — infant formula and supplements are filed under food) for active and past recall (cdp-bazaar)
• https://clinicalintelpulse.theaslangroupllc.com/api/clinical/global-trials Global clinical trial landscape for any disease — geographic distribution by country across WHO ICTRP registries (US, EU, China, India, Japan, Brazil, Africa an (cdp-bazaar)
• https://clinicalintelpulse.theaslangroupllc.com/api/clinical/mechanism-map Drug mechanism-of-action + molecular target landscape for any disease — targets in active trials, approved agents by MOA, crowded vs novel mechanisms and first- (cdp-bazaar)
• https://clinicalintelpulse.theaslangroupllc.com/api/clinical/sponsor-intel Pharma/biotech company pipeline intelligence — full drug pipeline by phase, therapeutic-area coverage, FDA approval history, partnerships, competitive positioni (cdp-bazaar)
• https://clinicalintelpulse.theaslangroupllc.com/api/clinical/pipeline-scan Clinical trial pipeline scan for any disease — all active Phase 2/3 trials with trial counts, sponsor landscape, geographic distribution, mechanism breakdown an (cdp-bazaar)
• https://clinicalintelpulse.theaslangroupllc.com/api/clinical/patient-finder Recruiting clinical trial finder for a disease or diagnosis — actively recruiting trials with plain-language summaries, eligibility (who can/cannot join), count (cdp-bazaar)
• https://clinicalintelpulse.theaslangroupllc.com/api/clinical/failure-analysis Clinical trial failure analysis for a disease area — why Phase 2/3 trials failed (wrong target, patient population, endpoint, dose, safety), failure taxonomy wi (cdp-bazaar)
• https://clinicalintelpulse.theaslangroupllc.com/api/clinical/deal-signal-lite Deterministic preview of biotech M&A deal-signal candidates — Phase 2/3 trial counts and the industry-sponsored asset list straight off ClinicalTrials.gov, no L (cdp-bazaar)
• https://clinicalintelpulse.theaslangroupllc.com/api/clinical/approval-outlook FDA/EMA drug approval probability + PDUFA calendar for a disease area — which Phase 3 drugs are most likely to win approval in 12-24 months, with mechanism, tri (cdp-bazaar)
• https://clinicalintelpulse.theaslangroupllc.com/api/clinical/disease-landscape Competitive drug pipeline landscape for any disease — full Phase 2/3 trial map, mechanism-of-action coverage, approved drugs, PDUFA calendar, M&A activity, oppo (cdp-bazaar)
• https://clinicalintelpulse.theaslangroupllc.com/api/clinical/disease-landscape-lite Deterministic preview of the disease pipeline landscape — Phase 2/3 trial counts, sponsor rollup, trial-status breakdown and a sample of trials straight off Cli (cdp-bazaar)

Seller? Reply or dispute. Amounts are in the asset's atomic units (USDC: 6 decimals).